Inbilt-F Solution

Inbilt-F Solution is a clinically formulated topical treatment for hair loss and thinning, especially androgenetic alopecia in men and women. Enriched with Minoxidil and Finasteride, it works by improving scalp blood circulation, stimulating hair follicles, and reducing hormonal hair fall. With regular use, it helps increase hair density, strengthen roots, and restore confidence.

• Minoxidil – Stimulates hair follicle activity & boosts regrowth
• Finasteride – Reduces DHT, the hormone responsible for hair thinning
• Ethanol & Propylene Glycol – Enhance penetration into scalp
• Purified Water – Solution base

FAQs

Q1. How does the Minoxidil and Finasteride combination in Inbilt-F Solution work differently from single-active treatments?
A1. The two actives address hair loss through entirely different mechanisms, making the combination significantly more effective than either alone. Minoxidil opens ATP-sensitive potassium channels in scalp blood vessel smooth muscle, causing vasodilation that increases blood flow and oxygen delivery to follicles — it also upregulates VEGF (Vascular Endothelial Growth Factor), which directly stimulates follicle growth and prolongs the anagen (active growth) phase. Finasteride is a selective Type II 5-alpha reductase inhibitor: it blocks the conversion of testosterone into DHT (dihydrotestosterone) in scalp tissue. In androgenetic alopecia, DHT binds to androgen receptors in follicles and progressively miniaturises them — Finasteride interrupts this hormonal miniaturisation process at its root cause. The combination therefore both removes the trigger (DHT) and actively stimulates regrowth simultaneously.

Q2. Why is topical Finasteride in Inbilt-F Solution considered safer than oral Finasteride tablets?
A2. Topical delivery keeps the active at the scalp site with minimal systemic absorption compared to oral Finasteride tablets. Clinical data shows topical Finasteride achieves scalp DHT suppression comparable to oral doses while producing significantly lower serum Finasteride and serum DHT reduction — the systemic hormonal exposure that drives oral Finasteride's reported side effects (libido changes, sexual dysfunction) is substantially reduced with the topical route. This localised pharmacology makes topical Finasteride the preferred format for patients who need DHT blockade without the systemic hormonal suppression of oral therapy. Use must still be doctor-supervised.

Q3. When should results be expected and is long-term use necessary?
A3. Initial shedding in the first 4–6 weeks is a normal sign that hair cycles are synchronising — do not discontinue use. Most users see visible improvement in density and thickness between months 3–6 of consistent daily application. Maximum benefit typically appears between months 9–12. Hair gains with this solution are maintenance-dependent: Minoxidil and Finasteride do not cure androgenetic alopecia — they suppress the hormonal and vascular factors driving it. Stopping treatment reverses the benefit within 3–6 months as DHT-mediated miniaturisation resumes and the enhanced follicle blood flow reverts.

Q4. Can women use Inbilt-F Solution?
A4. Inbilt-F Solution is generally NOT suitable for women of childbearing age. Finasteride is a Category X teratogen — it causes feminisation of male foetal genitalia even through topical exposure during pregnancy. Women who are pregnant, planning pregnancy, or breastfeeding must not use or even handle this product. Postmenopausal women may use it under strict dermatologist supervision, as the DHT-blocking mechanism can help female-pattern hair loss in hormonal profiles where androgen sensitivity is elevated. Both men and women using this solution should have baseline liver function and hormone screening done before starting, as recommended by their prescribing doctor.

Q5. What should not be used alongside Inbilt-F Solution?
A5. Avoid applying other topical hair treatments (oils, serums, growth serums) at the same time as application — these dilute the formula and create a physical barrier that blocks scalp penetration of Minoxidil and Finasteride. Do not use on irritated, sunburnt, or broken skin. Avoid oral 5-alpha reductase inhibitors (Dutasteride, oral Finasteride tablets) simultaneously without medical review — combining topical and oral DHT blockers multiplies systemic suppression. Alcohol-based scalp products applied shortly before or after can interfere with the solution's penetration matrix.

Country of Origin: India
Mfg/Marketer details: Cymbiotics Biopharma Pvt. Ltd., Plot No. 38 & 39, Sector-11, IIE, Sidcul, District Haridwar, Uttarakhand - 249403, India
Shelf Life: 24 months from manufacturing date
Storage: Store in a cool, dry place away from direct sunlight
Safety Information: For external use only. Use only as directed by your doctor. Avoid contact with eyes. Keep out of reach of children.